Hereditary haemorrhagic telangiectasia (HHT) is diagnosed clinically by the Curaçao Criteria of spontaneous recurrent nosebleeds, mucocutaneous telangiectasia at characteristic sites, visceral ...

The FDA has approved ENCELTO, the first treatment for macular telangiectasia type 2 (MacTel), a rare degenerative eye disease that gradually impairs central vision. ENCELTO is a surgically implanted ...

Type 2 macular telangiectasia, sometimes abbreviated as MacTel2, is much more common. With Type 2, the blood vessels in the macula become dilated and leak fluid, causing swelling and scarring, which ...

ART0380 in combination with low-dose irinotecan demonstrated a 50% confirmed overall response rate (cORR) in patients with Ataxia-Telangiectasia Mutated (ATM)-negative 1 solid tumors at the ...

2. Neurotech Pharmaceuticals, Inc. announces positive phase 3 topline results for NT-501 implant in macular telangiectasia type 2. News release.

The FDA approved Encelto, an encapsulated cell therapy, for the treatment of macular telangiectasia type 2, according to a press release from Neurotech Pharmaceuticals. The decision was supported ...

The Food and Drug Administration (FDA) has approved Encelto ™ (revakinagene taroretcel-lwey) for the treatment of macular telangiectasia type 2 (MacTel). MacTel is a rare, progressive eye ...

Access free, up-to-date clinical guidance about the clinical presentation of dermatomyositis on Healio. Our content provides valuable insights for physicians.

Telangiectasia refers to small, dilated blood vessels visible near the skin or mucous membranes' surface, often appearing on the face, legs, chest, or other areas. These vessels may be red, blue ...

Dr. Amir Bajoghli and Skin & Laser Dermatology Center are excited to introduce advanced laser treatments for telangiectasia, offering patients effective solutions to reduce the appearance of small, ...

On examination, it was observed: important periocular edema, reddish-wine-colored; erythematous-violaceous papules on the anterior thighs, arms, forearms, knees, elbows, metacarpophalangeal and ...

Intraocular implantation of NT-501 (Neurotech Pharmaceuticals, Inc.) — a cell therapy treatment for patients with macular telangiectasia type 2 (MacTel2) — is well-tolerated and correlates with a ...